1. Indonesia Stocks

  2. •

    Finance

  3. •

    Financial conglomerates
PT Saratoga Investama Sedaya Tbk

PT Saratoga Investama Sedaya Tbk

0.09
EUR
+0.00
(-0.55%)
0.17EPS
0.39P/E
928.16MMarket Cap
Nov 02Next Earn
PT Saratoga Investama Sedaya Tbk
GETTEX:ZY8
(Gettex)

Recent

price

0.09

P/E

ratio

0.39

div

yld

- -

ROIC.AI

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
IDR
545.08
283.39
451.45
452.34
525.89
287.41
-450.19
607.74
679.45
1,933.11
469.29
-813.55
393.43
517.19
3,839.44
Revenue per Share
419.92
19.05
46.05
68.08
418.26
241.53
-456.83
543.57
652.73
1,845.96
341.77
-750.46
242.99
540.24
3,557.87
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
18.6
17.4
14.81
21.99
11.02
21.98
59.96
74.95
21.99
14.75
- -
Dividend per Share
708.36
767.42
774.66
776.82
1,400.8
1,625.05
1,154.51
1,676.29
2,329.53
4,148.53
4,425.28
3,598.32
3,820.44
4,346.22
3,960.79
Book Value per Share
700.94
759.81
763.21
769.28
1,400.78
1,625.04
1,154.51
1,676.29
2,329.53
4,148.53
4,425.28
3,598.32
3,820.44
4,346.22
3,960.79
Tangible Book Value per Share
4,326
12,911
13,565
13,564
13,556
13,555
13,560
13,560
13,521
13,483
13,507
13,525
13,541
13,547
3,388
Basic Weighted Avg Shares
2,358,101
3,658,760
6,123,875
6,135,568
7,129,002
3,895,969
-6,104,643
8,241,125
9,186,701
26,064,901
6,338,674
-11,003,035
5,327,290
7,006,519
13,007,917
Sales/Revenue/Turnover
6.23
4.81
8.4
40.22
98.11
94.86
102.27
98.09
98.02
99.41
96.63
102.02
95.64
96.68
98.36
Operating Margin (%)
5,275
5,590
6,795
6,870
1,436
1,360
1,045
818
804
831
969
1,264
1,219
3,674
5,375
Depreciation Expense
1,816,612
245,914
624,695
923,407
5,669,928
3,274,027
-6,194,577
7,371,033
8,825,428
24,889,900
4,616,367
-10,149,771
3,290,197
7,318,796
12,053,982
Net Income, GAAP
1.36
10.8
13.06
13.41
13.39
2.74
- -
5.09
- -
3.13
21.04
- -
33.03
- -
4.78
Effective Tax Rate (%)
77.04
6.72
10.2
15.05
79.53
84.04
101.47
89.44
96.07
95.49
72.83
92.25
61.76
104.46
92.67
Profit Margin (%)
1,683,478
-566,792
1,057,624
-1,701,506
1,059,482
1,397,299
1,093,313
802,980
503,204
1,305,800
2,078,679
1,789,154
2,124,347
1,657,785
1,736,709
Working Capital
2,677,136
3,417,442
3,912,372
1,766,672
4,574,832
3,424,052
3,937,919
3,325,186
3,229,558
3,935,393
1,544,224
926,106
3,213,975
1,450,471
1,148,188
LT Debt
9,730,315
10,667,709
11,072,432
11,480,784
19,366,537
22,287,359
15,964,248
22,774,165
31,396,627
56,014,782
59,816,437
48,788,224
51,772,808
58,918,834
53,698,231
Total Equity
- -
0.16
2.38
12.88
28.61
14.05
- -
33.26
- -
53.21
8.01
- -
6.52
- -
23.66
Return on Invested Capital (%)
- -
2.92
4.04
4.51
28.71
14.79
- -
33.47
- -
53.02
7.84
- -
6.48
- -
23.61
Return on Capital (%)
- -
2.46
5.97
8.78
38.42
15.96
-32.87
38.41
32.62
56.98
7.97
-18.71
6.55
13.23
24.27
Return on Common Equity (%)

Capital Structure

IDR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
- -
- -
- -
LT Borrowings
1,450,471
795,960
1,148,188
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
13,550
13,550
13,550
Market Capitalization
20,567,631
26,883,426
19,041,509

Working Capital

IDR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
1,704,987
903,481
1,768,565
Cash, Cash Equivalents & STI
966,366
870,895
1,628,593
Accounts Receivable, Net
731,694
27,002
130,965
Inventories
- -
- -
- -
Total Current Liabilities
47,202
30,339
31,856
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

IDR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
22.26%
17.34%
13.8%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
-24.6%
-45.85%
122.44%
Sales/Revenue/Turnover
-79.18%
-56.49%
31.52%
Total Cash Common Dividend
- -
38.77%
-32.89%

Quarterly Revenue

IDR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-2,176,728
2,326,151
6,534,480
-1,356,613
5,327,290
2025
-6,769,202
6,239,397
- -
9,908,315
7,006,519
2026
6,916,884
-10,056,679
- -
- -
- -

Quarterly Earnings Per Share

IDR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-190.41
2,764,409.64
7,055,511.73
-2,376,961.72
242.99
2025
-448.6
8,666,355.03
- -
14,085,596.84
540.24
2026
392.73
-13,840,041.47
- -
- -
- -

Quarterly Dividends Per Share

IDR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
21.99
2025
- -
- -
- -
- -
14.75
2026
- -
- -
- -
- -
- -
Similar Companies
Strategy Inc (NASDAQ:MSTR)
BitMine Immersion Technologies, Inc. (NYSE:BMNR)
Strive, Inc. (NASDAQ:ASST)
Hyperliquid Strategies Inc (NASDAQ:PURR)
Stablecoin Development Corporation (AMEX:SDEV)
Jio Financial Services Limited (NSE:JIOFIN)
Business
PT Saratoga Investama Sedaya Tbk PT Saratoga Investama Sedaya Tbk is an Indonesia-based active investment company that manages over USD 3 billion in assets and focuses on high-growth sectors including healthcare, digital infrastructure, consumer goods, green economy, energy, precious metals, and specialty logistics; its core portfolio encompasses significant stakes in blue-chip companies such as PT Alamtri Resources Indonesia Tbk (formerly PT Adaro Energy Tbk), PT Adaro Andalan Indonesia Tbk, PT Merdeka Copper Gold Tbk, PT Tower Bersama Infrastructure Tbk, PT Mitra Pinasthika Mustika Tbk, PT Merdeka Battery Materials Tbk, Primaya Hospital, MGM Bosco Logistics, Samator Industrial Gas, Brawijaya Hospital, Forest Carbon, and Xurya, spanning construction, energy and resources, industrials, renewables, technology infrastructure, healthcare products and services, and digital media; the company provides financial support, operational expertise, and strategic guidance to these investee companies to drive sustainable growth across Indonesia and Southeast Asia. Founded in 1997 and headquartered in Jakarta, Indonesia, PT Saratoga Investama Sedaya Tbk listed on the Indonesia Stock Exchange in 2013 and operates through subsidiaries including PT Saratoga Sentra Business, PT Nugraha Eka Kencana, and others, targeting growth-stage and special situations investments with a track record of successful IPOs, divestments, and value creation in natural resources, infrastructure, and consumer sectors. In recent developments, the company acquired a majority stake in Brawijaya Hospital, one of Indonesia's largest women and children hospital groups, divested its stake in Deltomed Laboratories, supported the listing of PT Adaro Andalan Indonesia Tbk following the divestment of its thermal coal business by PT Alamtri Resources Indonesia Tbk, advanced low-carbon initiatives through investments in Forest Carbon for carbon sales and Xurya for rooftop solar energy with 186 assets operational and 43 under construction, and partnered on IPO preparations for entities like PT Famon Awal Bros Sedaya Tbk through its healthcare portfolio, all within 2024 amid a combined listed portfolio market capitalization exceeding USD 21 billion.